Sofinnova
sofinnovapartners.com Direct investor
Venture capital firm managing €4 billion+ with 500+ companies backed over 50 years. Focuses on breakthrough innovations in life sciences, healthtech, and sustainable biotech across seven specialized investment strategies.
Sofinnova is a venture capital firm headquartered in Paris, France, founded in 1972. It invests directly in companies, from seed to growth, in biopharma, medtech, digital medicine and agriculture. €4B+ under management and 500 portfolio companies, as it reports.
“We're investing in a better future for people and the planet.”
— Sofinnova, own website
- Layer
- Direct investor
- Type
- Venture capital
- Invests in
- Europe, global
- Sectors
- biopharma, medtech, digital medicine, agriculture, industrial biotech
- Founded
- 1972
- Assets under management
- €4B+
- Portfolio
- 500 companies
Team, as Sofinnova publishes it
- Graziano Seghezzi Managing Partner
- Antoine Papiernik Chairman & Managing Partner
- Henrijette Richter Managing Partner
Names and roles exactly as listed on sofinnovapartners.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 96 co-investors found.
- Andera Partners 7 shared companies: abivax.com, bioptimus.com, crescendobiologics.com, enyopharma.com…
- M Ventures 7 shared companies: artiospharma.com, asceneuron.com, discopharma.de, dnascript.com…
- Sofinnova Investments, INC. 5 shared companies: ascendispharma.com, cincor.com, nucana.com, obseva.com…
- Kurma Partners 4 shared companies: amolytpharma.com, asceneuron.com, dnascript.com, meiogenix.com
- Aisling Capital Management LP 4 shared companies: ascendispharma.com, f2g.com, obseva.com, veronapharma.com
- Indaco Venture Partners SGR 4 shared companies: biovelocita.com, freyabiosciences.com, genespire.com, pi-cardia.net
- IP Group plc 3 shared companies: artiospharma.com, crescendobiologics.com, missiontherapeutics.com
- RA Capital Management 3 shared companies: ascendispharma.com, cellcentric.com, hemab.com
- Astellas Venture Management 3 shared companies: catamaranbio.com, crescendobiologics.com, f2g.com
- Atlas Venture 2 shared companies: aavantgardebio.com, hotspotthera.com
and 86 more — the graph.
Where this comes from
Every fact above was read from a page Sofinnova publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- http://www.sofinnovapartners.comis_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, aum, portfolio_count
- https://www.wikidata.org/wiki/Q7553758founded, hq_country
- https://sofinnovapartners.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, founded, aum, portfolio_count, people, status, confidence
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 84 · added 2026-08-27 · link last verified 2026-09-06 · confidence high
Similar investors
- Citizen CapitalVenture capital · Growth · Paris, France
- Jeito CapitalVenture capital · Series A – Growth · Paris, France
- Truffle CapitalVenture capital · Seed – Growth · Paris, France
- 199 VenturesVenture capital · Paris, France
- ADNEXUSVenture capital · Pre-seed – Series A · Paris, France
- Aglaé VenturesVenture capital · Seed – Growth · Paris, France